ライフサイエンスコーパス: functional status

1 measure of autonomic symptoms and autonomic functional status).

2 nt profile, and improved quality of life and functional status.

3 frail populations, because of confounding by functional status.

4 tions, incidence of surgical procedures, and functional status.

5 factors, subclinical CVD, comorbidities, and functional status.

6 tal tool for the evaluation of cognitive and functional status.

7 nied by improvements in peripheral edema and functional status.

8 ve replacement to improve their survival and functional status.

9 patient had an early return to his baseline functional status.

10 mmonly used as an indicator of mitochondrial functional status.

11 n, diabetes, heart disease, and preinfection functional status.

12 omes were in-hospital mortality, independent functional status.

13 nt demographics, comorbidities, and baseline functional status.

14 nt in situ technique is lacking for tracking functional status.

15 itating, leading to poor quality of life and functional status.

16 eyond that provided by mitral valve area and functional status.

17 GE-rate (p < 0.05) than those with preserved functional status.

18 st patients may not regain their prefracture functional status.

19 and tensin homolog deleted on chromosome 10 functional status.

20 were changes in weight, CPAP adherence, and functional status.

21 ation, and utility associated with patients' functional status.

22 hose reactions on subsequent psychiatric and functional status.

23 ors, white matter hyperintensity volume, and functional status.

24 ity to assess how these comorbidities affect functional status.

25 ery hospital day until achieving independent functional status.

26 al DVT, low expected bleeding risk, and good functional status.

27 ered "too ill/old" were advanced age and low functional status.

28 hage removal via alteplase produces gains in functional status.

29 tion about the impact of HF interventions on functional status.

30 uding readmission, primarily due to impaired functional status.

31 e was not associated with downstream patient functional status.

32 s' asthma exacerbations on their caregivers' functional status.

33 nterventions on heart failure (HF) patients' functional status.

34 r assessing mobility to predict mortality or functional status.

35 No studies examined functional status.

36 italization for a respiratory condition, and functional status.

37 ed P = .047) and less than fully independent functional status (12% recurrence rate with impaired fun

38 This study examined the distribution of functional status 3 months after stroke, determined whet

39 ta Living With Heart Failure Questionnaire), functional status (6-minute walk test, peak maximum oxyg

40 were identified: type of surgery, dependent functional status, abnormal creatinine, American Society

41 tically overlap in rodents, with the 5-HT2CR functional status acting as a neural rheostat to regulat

42 t Walk, Low-Contrast Letter Acuity), general functional status (Activities of Daily Living), and card

43 on, Modified Mini-Mental State Examination), functional status (activities of daily living, instrumen

44 1.14-1.32) and have an unfavorable discharge functional status (adjusted odds ratio, 1.13; 95% CI: 1.

45 the association of long-term opioid use with functional status, adverse outcomes, and mortality among

46 the association of long-term opioid use with functional status, adverse outcomes, and mortality.

47 he embolism formation/removal affects vessel functional status after sample excision.

48 tions with limited ability to preserve their functional status, aggressive treatments, including surg

49 cannot be ruled out as a source of worsened functional status among patients receiving long-term opi

50 d associations between TNFR1 and 1) baseline functional status and 2) change in function over time, a

51 Among the participants, 49% had poor functional status and 76% had musculoskeletal pain.

52 but commonly reported gratitude for improved functional status and a perception of improved symptom b

53 Secondary outcomes included discharge functional status and adverse drug-related effects.

54 where targeted medical therapies may improve functional status and allow successful transplantation i

55 d life expectancy derived from evaluation of functional status and comorbidity.

56 ork is important financially, as a marker of functional status and for self-esteem in patients develo

57 geal cancer, there is an increasing focus on functional status and health-related quality of life in

58 T provided comparable durable improvement in functional status and in quality of life up to 18 months

59 d APOE4 carriers, and performed less well on functional status and learning and memory than N- subjec

60 udinal in vivo imaging approach, we show how functional status and mass of beta-cells adapt in respon

61 Functional status and physical quality of life at 6 mont

62 r emphasis on the impact of these factors on functional status and psychosocial adjustment.

63 Improving functional status and quality of life are important goal

64 More comparative studies on functional status and quality of life are needed for inf

65 llness and can have significant effects upon functional status and quality of life.

66 parable short-term (6-month) improvements in functional status and quality of life.

67 by significant improvements in survival and functional status and reduction in implantation costs.

68 stry and Medicare claims lack information on functional status and severity of comorbidity, which mig

69 exia, a condition that significantly impairs functional status and survival.

70 into the systemic RV can be used to improve functional status and to delay the progression of ventri

71 Key efficacy end points were functional status and ventricular function while tempora

72 propriate (focused initially on symptoms and functional status); and increased FDA and industry train

73 clinical stage 1 disease, 364 (99%) had high functional status, and 353 (96%) delivered vaginally.

74 ic factors such as life expectancy, impaired functional status, and cognitive decline warrant conside

75 ity, laboratory results, quality of life and functional status, and GI tract imaging.

76 lower preoperative serum albumin, had worse functional status, and had higher American Society of An

77 nic care facility or nursing home, dependent functional status, and higher American Society of Anesth

78 therapy (CRT) decreases mortality, improves functional status, and induces reverse left ventricular

79 therapy (CRT) decreases mortality, improves functional status, and induces reverse left ventricular

80 tilator- and vasoactive-free days at Day 28, functional status, and mortality.

81 sleep apnea, diabetes, and hyperlipidemia), functional status, and patient satisfaction.

82 ing diagnosis, pain severity, pain duration, functional status, and prior resource use.

83 luded ICU admission rate, in-hospital death, functional status, and quality of life (12-Item Short Fo

84 es care include maintenance of independence, functional status, and quality of life by reduction of s

85 , responsive, and valid measure of symptoms, functional status, and quality of life in patients with

86 Improvements in left ventricular function, functional status, and quality of life were observed in

87 echocardiographic indexes of valve stenosis, functional status, and quality of life.

88 s in walking speed, motor recovery, balance, functional status, and quality of life.

89 asis, other psychopathology, adverse events, functional status, and quality of life.

90 ular risk factors, multisystem disease, poor functional status, and so on), the thoroughness of the p

91 o, 16.273; 95% CI, 12.028-22.016), dependent functional status, and the need for a higher level of ca

92 Educational level, functional status, and the patient's role in decision ma

93 iagnosed with acute PE in U.S. EDs have high functional status, and their mortality rate is low.

94 entilator, ICU, and hospital days; discharge functional status; and mortality.

95 that race or ethnicity, social support, and functional status are independently associated with trea

96 Although measures of functional status are often advocated when assessing sho

97 y of life, global change (overall, pain, and functional status), arthritis self-efficacy, coping, and

98 This study demonstrates that preoperative functional status as measured by FI and SF-36 may help i

99 can significantly improve resident pain and functional status as well as clinical practice behaviour

100 strategies separate patients based on age or functional status as well as genetics [presence or absen

101 could be found in terms of post-intervention functional status as well as improvement in New York Hea

102 health, health-related quality of life, and functional status, as assessed with the use of questionn

103 tive was to evaluate the association between functional status, as measured by Karnofsky Performance

104 pectations, comorbidities, and cognitive and functional status, as well as coordinating community res

105 we also describe a pragmatic approach toward functional status assessment in the hospital focused on

106 Functional status assessment may be a useful tool with w

107 Functional status assessment methods are important as ou

108 d with a negative, equivocal, or unperformed functional status assessment.

109 se (MELD) >/=12 at a single center underwent functional status assessments at every outpatient visit

110 f survival time, impaired consciousness, and functional status at 3 months and 6 months and neuropsyc

111 association between frailty and mortality or functional status at 6 months or later in patients aged

112 rolonged intensive care unit stays, and poor functional status at discharge (P < 0.05).

113 ality in patients with marked improvement in functional status at discharge was 64% less than patient

114 ) is independently associated with favorable functional status at hospital discharge (odds ratio, 0.8

115 We sought to examine the association between functional status at hospital discharge in survivors of

116 Lower functional status at hospital discharge in survivors of

117 Functional status at hospital discharge may be a risk fa

118 tic regression model, the lowest quartile of functional status at hospital discharge was associated w

119 s) on the basis of measures of cognitive and functional status available for all HRS respondents, the

120 Results of VA testing and self-reported functional status based on activities of daily living (A

121 er, long-term opioid therapy did not improve functional status but rather was associated with a highe

122 e tissue-specific changes) and assessment of functional status can be valuable in the management of s

123 e was also greater improvement in cognition, functional status, caregiver burden, CGI scores, and dep

124 Methylphenidate also improved cognition, functional status, caregiver burden, CGI scores, and dep

125 the following domains be evaluated in a GA: functional status, comorbidity, cognition, mental health

126 The assessment measures functional status, comorbidity, cognitive function, psyc

127 icantly reduced residents' pain and improved functional status compared to usual care without access

128 splantation survival with pretransplantation functional status data (physical function [PF] scale of

129 Functional status declines with aging, thus impeding aut

130 Serum ES correlated with poor functional status, decreased exercise tolerance, and inv

131 ted for demographics, body mass index (BMI), functional status, depression, medications, alcohol, caf

132 The exposure of interest was functional status determined at hospital discharge by a

133 Increasing age, impaired functional status, Do-Not-Resuscitate status, impaired r

134 Patient-reported functional status, documented adverse outcomes, and mort

135 evelop and validate a measure of caregivers' functional status during a preschooler's asthma exacerba

136 Few instruments exist to measure caregivers' functional status during a young child's asthma exacerba

137 icant improvement in all-cause mortality and functional status during early and 3-year follow-up.

138 ntify lung function, confirm an individual's functional status, evaluate regimen effectiveness, and d

139 kidney transplant recipients with the lowest functional status experienced modest improvements in fun

140 ives included changes in 24-week end points, functional status (FACT-Trial Outcome Index [TOI]), fati

141 ndicators of asthma control (symptoms and/or functional status); failed to provide a distinct, reliab

142 We ascertained pre- and postmorbid functional status from survey data.

143 There are limited data describing the functional status (FS) of children after heart transplan

144 one of the most frequently used measures of functional status (Functional Activities Questionnaire a

145 National Institutes of Health Stroke Scale), functional status (functional independence measure score

146 the postchemotherapy setting, thereby their functional status governs the choice between eradication

147 Measures of symptom and functional status, health perceptions, quality of life,

148 0.45 to 0.64), as were patients with better functional status (higher Palliative Performance Scale s

149 I components using Harrell ranking, impaired functional status, identified as nonindependent function

150 Quality of life and functional status improved significantly in both groups.

151 r primary patency, lower CD-TLR, and similar functional status improvement with fewer repeat interven

152 Furthermore, patients whose functional status improves before discharge have decreas

153 alyses of data for patient-reported pain and functional status in a preplanned interim analysis of a

154 ations and their association with health and functional status in a recent cohort of hematopoietic ce

155 at home, managed by dialysis staff, improves functional status in adult patients on dialysis.

156 e, and immune recovery were used to estimate functional status in conditional logistic regression.

157 ioxidant that has been postulated to improve functional status in congestive heart failure (CHF).

158 , progression to chronic kidney disease, and functional status in daily living.

159 tivity is a measure of HF-related and global functional status in HF with preserved ejection fraction

160 TAVR resulted in better survival and functional status in inoperable patients with severe aor

161 broader constructs such as health status or functional status in IPF.

162 ficant difference in patient satisfaction or functional status in late follow-up (1-73 months).

163 iated with less atrophy and better long-term functional status in older adults with chronic ischemic

164 Older age is an independent predictor of functional status in patients with DCM.

165 othetical scenario that recipients with poor functional status in this cohort experienced modest impr

166 hemodynamics, RV structure and function, and functional status in treatment-naive patients with SSc-P

167 All patients had improvements in functional status, in exercise capacity as evaluated by

168 ncluding family life and relationships); and functional status (including return to work and previous

169 loyment clinical assessment as well as later functional status, including evaluation of occupational

170 rm mortality, increased risk of stroke, poor functional status, increased hospital readmissions and s

171 ge and is associated with a major decline in functional status, increased myocardial infarction and s

172 re associated with long-term trajectories of functional status independently of vascular risk factors

173 ars or older, free of cancer, with preserved functional status (Index of Independence in Activities o

174 We sought to develop and validate a functional status instrument to assess asthma exacerbati

175 Functional status is a key patient-centric outcome, but

176 Functional status is an important determinant of posttra

177 RV function, reduce arrhythmia, and optimize functional status is lacking.

178 Linking of therapeutic targets to individual functional status is mandatory and very tight glucose co

179 h status (eg, quality of life, symptoms, and functional status) is poorly defined.

180 ost-LT transplant costs were older age, poor functional status (KPS 10%-40%), living donor LT, pre-LT

181 associated with higher mortality and reduced functional status, leading to higher rate of institution

182 ere receiving long-term opioids had multiple functional status markers that were modestly poorer even

183 justed odds ratio, 1.9; 95% CI, 1.4-2.6); no functional status markers were improved by long-term use

184 r, health and strategies to optimize patient functional status may help to reduce unplanned rehospita

185 ameters most closely correlated with current functional status may not be the parameters that are mos

186 of frailty preoperatively, such as improving functional status, may improve perioperative outcomes an

187 MSA-C (n=49) had much the same symptoms and functional status: mean UMSARS I 25.2 (SD 8.08) versus 2

188 The primary endpoint was back-specific functional status measured by the Roland-Morris disabili

189 hazards models (adjusted for age, sex, PSI, functional status, medications) to determine rates and i

190 A summary measure of health such as functional status might enable transplant professionals

191 ver time and is predictive for the patient's functional status, muscle strength and mortality risk.

192 port leads to alterations in cardiac output, functional status, neurohormonal activity and transcript

193 d 313 (92.6%) of surviving patients had good functional status (New York Heart Association class I/II

194 ility of other long-term outcome data (e.g., functional status, nursing home admissions), and the ava

195 se cardiac arrest survivors, improvements in functional status occur over the first 6 months after th

196 ted with a significantly greater odds of low functional status (odds ratio, >/= 1.1 for all analyses;

197 was 64% less than patients with no change in functional status (odds ratio, 0.36 [95% CI, 0.24-0.53];

198 lity compared with patients with independent functional status (odds ratio, 7.63 [95% CI, 3.83-15.22;

199 se findings suggest that xerC may impact the functional status of agr.

200 investigated the expansion, maintenance, and functional status of antigen-specific CD4(+) T cells dur

201 Our findings provide new insights into the functional status of antigen-specific CD4(+) T cells mai

202 ating physiologic processes that control the functional status of Foxp3-lineage Tregs.

203 (Ago1) and Argonaute 2 (Ago2) to assess the functional status of individual miRNA species.

204 n is lacking on the morphologic features and functional status of mesenteric lymphatics in CD.

205 he high-mobility group box 1 (HMGB1), as the functional status of NAC1 was associated with the expres

206 exercise was the most effective in improving functional status of obese older adults.

207 ape immune responses in vivo and reflect the functional status of other subpopulations.

208 elomerase activity but is independent of the functional status of p53 and Rb.

209 on was to determine if the environmental and functional status of people with serious mental illness

210 easome-dependent oligopeptide generation and functional status of peptidases in Ag donor cells.

211 ferent phases, and changes in the amount and functional status of photosystem II (PSII) were investig

212 of septic acute kidney injury and impact on functional status of PICU survivors are unknown.

213 nformative diagnostic tool for assessing the functional status of spinal and supraspinal circuits.

214 We concluded that the functional status of T cells before and after liver tran

215 d that differences were a consequence of the functional status of the captured cells.

216 The overall functional status of the cytolytic compartment was studi

217 l and morphological parameters to assess the functional status of the endocrine pancreas.

218 olecular cochaperone that contributes to the functional status of the glucocorticoid receptor (GR) an

219 Our work established a link between the functional status of the lysosome in general to the Rag-

220 be guided by presumed risk of recurrence and functional status of the patient (important within the f

221 Therefore, the functional status of the TRPV4 channel in the distal nep

222 tail the different cell constituents and the functional status of the vasculature, and discuss prospe

223 sive and receptive agrammatism; however, the functional status of this region in nonfluent PPA is not

224 In conclusion, the functional status of TRPV4, which underlies mechanosensi

225 ture the intestinal barrier consists of, the functional status of which is described by 'intestinal p

226 verse relationship between Bcl6 and p53, the functional status of which is linked to each transcripti

227 ial information regarding the dimensions and functional status of xylem conduits during dehydration.

228 at nucleosome fragility underscores distinct functional statuses of the chromatin and provides a new

229 ween AF and exercise training on measures of functional status or clinical outcomes (all p > 0.10).

230 9; 95% CI, 3.46-3.71), and totally dependent functional status (OR = 2.27; 95% CI, 2.11-2.44).

231 ctional status, identified as nonindependent functional status (OR, 1.16; 95% CI, 1.11-1.21; P < .01)

232 dverse cardiac or cerebrovascular events, in functional status, or in quality of life at 12 months.

233 ticomponent instruments predicted mortality, functional status, or MACCEs, but the quality of evidenc

234 ailty instruments used to predict mortality, functional status, or major adverse cardiovascular and c

235 erebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year.

236 t experiences with care, including symptoms, functional status, or quality of life.

237 tory measures of ventricular performance and functional status over time.

238 s were related to New York Heart Association functional status (p < 0.0001) and the subsequent need f

239 tern is associated with lower FEV1 and worse functional status (P < 0.005).

240 ment evaluation were not predictive of later functional status (P = .12-.8).

241 lar ejection fraction (p = 0.001) and poorer functional status (p = 0.034) at 1-year follow-up.

242 d therapy, was also associated with improved functional status (P<0.001).

243 ies, decreased cognitive function, decreased functional status, parenteral nutrition, and pressure ul

244 t long-term survival and maintenance of good functional status post-PEA.

245 pensity matching to control for comorbidity, functional status, postoperative complications, and stag

246 r had a low KPS at transplantation had worse functional status posttransplantation when compared to t

247 Since recognition of functional status problems is an essential prerequisite

248 id conditions, which might negatively affect functional status, quality of life, and survival.

249 on final outcomes of interest--for example, functional status, quality of life, disability, major cl

250 8%, respectively; P<0.001); the score on the Functional Status Questionnaire, in which higher scores

251 s survival, quality-adjusted life-years, and functional status; receipt of social support, nutritiona

252 e assessment of change in sinus symptoms and functional status, recurrence or relapse, and satisfacti

253 18 years old or older, prearrest independent functional status, resuscitation from cardiac arrest, an

254 ymptoms (RRR 1.56, 95% CI 1.12, 2.17), lower functional status (RRR 2.46, 95% CI 1.21, 4.98) and self

255 ect or underlying disease/substrate, and the functional status (S) of the disease using both the Amer

256 attern (G), etiological information (E), and functional status (S).

257 nadjusted morbidity rates (measured with the Functional Status Scale and defined as an increase of >/

258 Functional Status Scale and POPC/PCPC scores determined

259 mission source, diagnostic factors, baseline Functional Status Scale, and the Pediatric Risk of Morta

260 g >/=1 year post-HT from 2005 to 2014 with a functional status score (FSS) available at 3 time points

261 The unadjusted Short Functional Status score (GC group only) declined from 4.

262 The clinical course using a functional status score (Japanese Orthopedic Association

263 y condition, an income <$35 000, and a lower functional status score (P < .01 for all).

264 ositive correlations (r = 0.30-0.95) between Functional Status Score for the ICU and other physical f

265 Functional Status Score for the ICU at ICU discharge pre

266 The Functional Status Score for the ICU demonstrated good to

267 The Functional Status Score for the ICU has good internal co

268 ity was demonstrated by significantly higher Functional Status Score for the ICU scores among patient

269 Responsiveness was supported via increased Functional Status Score for the ICU scores with improvem

270 % confidence interval 0.70-9.74; P=0.02) and functional status scores (+5.65, 95% confidence interval

271 isit 3: 70.8, 95% CI 65.3-76.3; P=0.016) and functional status scores (visit 1: 62.2, 95% CI 58.5-66.

272 ion; therefore, standardized measurements of functional status should be considered to optimize candi

273 Measures of patient functional status should be included in trials to better

274 uretic peptide (NT-proBNP)) and a measure of functional status (such as exercise capacity).

275 The Short Functional Status survey of 5 activities of daily living

276 serves as a robust biomarker for tumor LKB1 functional status that can be integrated into clinical t

277 2 clinically relevant factors (symptoms and functional status) that may predict TAVR outcomes.

278 rious protein sequence properties, including functional status, thermostability, enzyme activity, and

279 Despite the importance of functional status to older persons and their families, l

280 ents but 1 demonstrated improvements in NYHA functional status (to class II) with pronounced reductio

281 ts; however, the independent contribution of functional status towards costs is understudied.

282 This manuscript describes the functional status trajectory of older (age 65 or older)

283 effects are associated with poor health and functional status, underscoring the need for close follo

284 surgery, intraoperative adverse events, and functional status using 36-Item Short Form General Healt

285 rm survivors were assessed for cognitive and functional status (using Cerebral Performance Category a

286 al status (12% recurrence rate with impaired functional status vs 7% for fully independent; adjusted

287 Across a wide age range, functional status was an independent predictor of posttr

288 Functional status was assessed at baseline and at 2, 5,

289 Functional status was assessed by gait speed, instrument

290 Survival with improved functional status was better with HMII LVAD compared wit

291 ssessment of enrolled patients; survival and functional status was determined 12 months later.

292 T-cell phenotype (Th1/Th2/Th17/T-Reg) and functional status was evaluated using flow-cytometry and

293 Functional status was measured by Karnofsky performance

294 Functional status was significantly associated with new

295 but not with increased 30-day mortality, and functional status was significantly improved regardless

296 Symptom severity and functional status were also assessed.

297 Safety and functional status were assessed over 3 weeks of follow-u

298 Higher motor and cognitive functional status were associated with lower hospital re

299 eumonia over 5 years and those with impaired functional status were at particularly high risk.

300 amined the relationship between survival and functional status with multivariable Cox regression, adj